Study: Blood thinner has good, bad effects

Pfizer Inc. and Bristol-Myers Squibb Co. said Tuesday a midstage safety study showed their experimental blood thinner apixaban did increase patients' risk of bleeding, but may also reduce patients' risk of a second heart attack, ...

Read full post here.